These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 12637300)
1. Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy. Kalra S; Cashman NR; Caramanos Z; Genge A; Arnold DL AJNR Am J Neuroradiol; 2003 Mar; 24(3):476-80. PubMed ID: 12637300 [TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results. Kalra S; Genge A; Arnold DL Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):22-6. PubMed ID: 12745614 [TBL] [Abstract][Full Text] [Related]
3. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Kalra S; Cashman NR; Genge A; Arnold DL Neuroreport; 1998 Jun; 9(8):1757-61. PubMed ID: 9665596 [TBL] [Abstract][Full Text] [Related]
4. Detecting neuronal dysfunction of hand motor cortex in ALS: A MRSI study. Wang Y; Li X; Chen W; Wang Z; Xu Y; Luo J; Lin H; Sun G Somatosens Mot Res; 2017 Mar; 34(1):15-20. PubMed ID: 28114839 [TBL] [Abstract][Full Text] [Related]
5. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Pohl C; Block W; Karitzky J; Träber F; Schmidt S; Grothe C; Lamerichs R; Schild H; Klockgether T Arch Neurol; 2001 May; 58(5):729-35. PubMed ID: 11346367 [TBL] [Abstract][Full Text] [Related]
6. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Rooney WD; Miller RG; Gelinas D; Schuff N; Maudsley AA; Weiner MW Neurology; 1998 Jun; 50(6):1800-5. PubMed ID: 9633731 [TBL] [Abstract][Full Text] [Related]
7. Effect of creatine supplementation on metabolite levels in ALS motor cortices. Vielhaber S; Kaufmann J; Kanowski M; Sailer M; Feistner H; Tempelmann C; Elger CE; Heinze HJ; Kunz WS Exp Neurol; 2001 Dec; 172(2):377-82. PubMed ID: 11716561 [TBL] [Abstract][Full Text] [Related]
9. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. Chan S; Shungu DC; Douglas-Akinwande A; Lange DJ; Rowland LP Radiology; 1999 Sep; 212(3):763-9. PubMed ID: 10478245 [TBL] [Abstract][Full Text] [Related]
10. An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. Foerster BR; Pomper MG; Callaghan BC; Petrou M; Edden RA; Mohamed MA; Welsh RC; Carlos RC; Barker PB; Feldman EL JAMA Neurol; 2013 Aug; 70(8):1009-16. PubMed ID: 23797905 [TBL] [Abstract][Full Text] [Related]
11. ALS defeats gabapentin: reflections on another failed treatment. Brigell MG; Taylor CP Neurology; 2001 Oct; 57(8):1524-5. PubMed ID: 11673613 [No Abstract] [Full Text] [Related]
12. β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS. de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Ojeda I; Martínez A; Gil C; Arahuetes RM Environ Toxicol Pharmacol; 2013 Sep; 36(2):243-255. PubMed ID: 23688553 [TBL] [Abstract][Full Text] [Related]
13. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Rule RR; Suhy J; Schuff N; Gelinas DF; Miller RG; Weiner MW Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):141-9. PubMed ID: 15512902 [TBL] [Abstract][Full Text] [Related]
14. ALS surrogate markers. MRS. Kalra S; Arnold DL Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():111-4. PubMed ID: 15512889 [TBL] [Abstract][Full Text] [Related]
15. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Ellis CM; Simmons A; Andrews C; Dawson JM; Williams SC; Leigh PN Neurology; 1998 Oct; 51(4):1104-9. PubMed ID: 9781537 [TBL] [Abstract][Full Text] [Related]
16. The combined use of conventional MRI and MR spectroscopic imaging increases the diagnostic accuracy in amyotrophic lateral sclerosis. Cervo A; Cocozza S; Saccà F; Giorgio SMDA; Morra VB; Tedeschi E; Marsili A; Vacca G; Palma V; Brunetti A; Quarantelli M Eur J Radiol; 2015 Jan; 84(1):151-157. PubMed ID: 25466774 [TBL] [Abstract][Full Text] [Related]
17. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Suhy J; Miller RG; Rule R; Schuff N; Licht J; Dronsky V; Gelinas D; Maudsley AA; Weiner MW Neurology; 2002 Mar; 58(5):773-9. PubMed ID: 11889242 [TBL] [Abstract][Full Text] [Related]
18. Whole-brain analysis of amyotrophic lateral sclerosis by using echo-planar spectroscopic imaging. Verma G; Woo JH; Chawla S; Wang S; Sheriff S; Elman LB; McCluskey LF; Grossman M; Melhem ER; Maudsley AA; Poptani H Radiology; 2013 Jun; 267(3):851-7. PubMed ID: 23360740 [TBL] [Abstract][Full Text] [Related]
19. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Wang S; Poptani H; Woo JH; Desiderio LM; Elman LB; McCluskey LF; Krejza J; Melhem ER Radiology; 2006 Jun; 239(3):831-8. PubMed ID: 16641339 [TBL] [Abstract][Full Text] [Related]
20. Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis. Abe K; Takanashi M; Watanabe Y; Tanaka H; Fujita N; Hirabuki N; Yanagihara T Neuroradiology; 2001 Jul; 43(7):537-41. PubMed ID: 11512581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]